VUMC and Roivant Social Ventures Announce Collaboration to Develop Therapies for Underserved Populations

3 years ago

NEW YORK, July 06, 2022 (GLOBE NEWSWIRE) -- Vanderbilt University Medical Center (VUMC) and Roivant Social Ventures (RSV) announced an…

Teladoc Health Expands Innovative Whole-Person Primary Care Offering, Primary360

3 years ago

New Capabilities and Clients are Fueling the Award-Winning Primary Care ServicePURCHASE, NY, July 06, 2022 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:…

Better Choice Issues Shareholder Letter with Mid-Year Update on Recent Achievements

3 years ago

NEW YORK, July 06, 2022 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE: BTTR) (the “Company” or “Better Choice”), a…

FDA Approves Sientra’s Low Plus Profile Projection Breast Implant

3 years ago

New Implant Offers Surgeons and Their Patients More Options to Customize Their Surgical OutcomesSANTA BARBARA, Calif., July 06, 2022 (GLOBE…

Surgalign™ Announces Clinical Site Expansion in the Commercialization of its HOLO Portal™ Surgical Guidance System in Ohio

3 years ago

This marks the second medical facility to clinically use HOLO Portal, the world’s first artificial intelligence (AI)-driven, augmented reality (AR)…

Qualigen Therapeutics Announces Partnership with Hande Sciences To Scale-Up Manufacturing To Support IND-Enabling Studies for QN-302

3 years ago

CARLSBAD, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on…

Ozop Energy Solutions, Inc. to Report Substantial Revenue Growth for Q2 2022 Over 2021

3 years ago

Warwick, NY, July 06, 2022 (GLOBE NEWSWIRE) -- Ozop Energy Solutions. Inc. (OZSC), is pleased to announce that it expects…

TELUS Health reaches milestone – supports two million Canadians with access to their own digital personal health record

3 years ago

Since launching in Western Canada in 2019, TELUS Health’s Personal Health Record (PHR) solution has seen rapid growth helping more…

Sheba Medical Center and Enlivex Announce Dosing of the First Patient in Phase I/II Trial Evaluating Allocetra Combined with Chemotherapy in Patients with Peritoneal Metastases Arising from Solid Cancers

3 years ago

First clinical trial of Allocetra™ in patients with cancer builds upon promising preclinical studies demonstrating its broadly applicable immunotherapeutic effects…

The Lancet Gastroenterology & Hepatology Publishes Data from Albireo’s Landmark PEDFIC 1 Study of Bylvay® (odevixibat) Treatment in PFIC

3 years ago

First successful global gold standard pediatric Phase 3 trial ever conducted in cholestatic liver disease PEDFIC 1 & 2 studies…